Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
2020 · New England Journal of Medicine · 3,322 citations
https://doi.org/10.1056/nejmoa1911793
H
Harry J.M. Groen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
945
Papers
41.1K
Citations
89
h-index
402
i10-index
Harry J.M. Groen is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment & Lung Cancer Research Studies. The author has an h-index of 89, co-authored 804 publications.
ORCID: 0000-0002-2978-5265Papers by this author
worksComplication rates of CT-guided transthoracic lung biopsy: meta-analysis
2016 · European Radiology · 715 citations
https://doi.org/10.1007/s00330-016-4357-8
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
2017 · Journal of Clinical Oncology · 580 citations
https://doi.org/10.1200/jco.2016.71.5904
Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis
2017 · Nature Genetics · 433 citations
https://doi.org/10.1038/ng.3752
Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction
2010 · Nature Genetics · 355 citations
https://doi.org/10.1038/ng.716
Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study
2021 · Journal of Thoracic Oncology · 244 citations
https://doi.org/10.1016/j.jtho.2021.02.009
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat